<bill session="107" type="h" number="2153" updated="2013-07-14T18:57:46-04:00">
  <state datetime="2001-06-13">REFERRED</state>
  <status>
    <introduced datetime="2001-06-13"/>
  </status>
  <introduced datetime="2001-06-13"/>
  <titles>
    <title as="introduced" type="short">American Breakthrough Research Act of 2001</title>
    <title as="introduced" type="official">To provide for an election to exchange research-related tax benefits for a refundable tax credit, for the recapture of refunds in certain circumstances, and for other purposes.</title>
  </titles>
  <sponsor id="400085"/>
  <cosponsors>
    <cosponsor id="400063" joined="2001-07-19"/>
    <cosponsor id="400091" joined="2001-06-13"/>
    <cosponsor id="400184" joined="2001-06-13"/>
    <cosponsor id="400256" joined="2001-06-13"/>
    <cosponsor id="400263" joined="2001-06-13"/>
    <cosponsor id="400524" joined="2001-07-12"/>
    <cosponsor id="400326" joined="2002-02-28"/>
    <cosponsor id="400509" joined="2001-06-13"/>
  </cosponsors>
  <actions>
    <action datetime="2001-06-13">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1094"/>
    </action>
    <action state="REFERRED" datetime="2001-06-13">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="Business income tax"/>
    <term name="Business losses"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Corporation taxes"/>
    <term name="Health"/>
    <term name="Income tax"/>
    <term name="Orphan drugs"/>
    <term name="Pharmaceutical research"/>
    <term name="Research and development tax credit"/>
    <term name="Science, technology, communications"/>
    <term name="Tax deductions"/>
    <term name="Tax penalties"/>
    <term name="Tax refunds"/>
  </subjects>
  <amendments/>
  <summary>6/13/2001--Introduced.
American Breakthrough Research Act of 2001 - Amends the Internal Revenue Code to allow a qualified research corporation to elect a refundable credit in the amount of the sum of the discounted research credits and discounted research net operating loss (NOL) in lieu of taking its research credits and research NOLs. (Defines terms for purposes of such credit.)Prohibits an electing corporation from using nonrelinquished research or NOL tax credits until such corporation has paid back the original amount of the refundable credit in Federal income taxes.Provides for credit recapture in the event of failure to increase research activity.</summary>
</bill>
